MMV deeply saddened by the loss of Dr Ricardo Thompson

Passionate Mozambican health research scientist will be sorely missed

26 Jun 2020

The team at MMV was deeply saddened to learn of the sudden loss of Dr Ricardo Thompson who passed away on Sunday, 21 June 2020. Having collaborated with Dr Thompson on numerous clinical trials over the years, MMV as well as the health research community has lost a brilliant and engaging scientist and dedicated clinical trialist.

 MMV’s collaboration with Dr Thompson dates back to 2006 when he was Principal Investigator in Mozambique for the Phase III clinical trial of Pyramax® (pyronaridine-artesunate). Since then, numerous members of the MMV team had the pleasure of working with Dr Thompson on other clinical studies up until his untimely passing this week.   

Dr Thompson’s commitment to improving health in his native Mozambique knew no bounds – it was expressed in numerous ways, not least via the clinical, epidemiological, and social research at which he excelled. He was a man of vision and heart. He was passionately engaged, questioning, and fair – a great collaborator and a supportive mentor. He was firmly committed to the fight against malaria and to developing sustainable African research capacity, particularly at the Chókwè Health Research and Training Centre (CITSC), which he founded in 2007 and was Director and Principal Investigator.

Among his other accolades, he was Scientific Director at the National Institute of Health in Maputo, where his impressive and tireless work was instrumental in introducing antiretrovirals for HIV-AIDS to Mozambique.

His loss brings home the fragility of life and the importance of filling it with family, friends and colleagues, which he did impeccably well.

MMV extends sincere condolences to Dr Thompson’s family, friends and colleagues. He will be sorely missed by us and the wider health research community.